Browsing by Author Furberg, C

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2003Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatmentKeech, Anthony (Tony); Frohlich, J; Furberg, C; Jungner, I; Roeters van Lennep, J E; Sniderman, A D; Walldius, G; School of Public Health: NH&MRC Clinical Trials CentreApolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment, The Lancet, vol.361,(9359),2003,pp 777-780
2005Effect of pravastatin in people with diabetes and chronic kidney disease.Keech, Anthony (Tony); Simes, Robert John; et, al; Furberg, C; Isles, Chris; Packard, Chris; Pfeffer, M; Sacks, Frank; Shepherd, Jim; Tonelli, Marcello; Tonkin, Andrew; West, Malcolm; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffect of pravastatin in people with diabetes and chronic kidney disease., Journal of the American Society of Nephrology, vol.16,(12),2005,pp 3748-3754
2005Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease.Simes, Robert John; Cobbe, Stuart M; Craven, Timothy; et, al; Furberg, C; Isles, Chris; Pfeffer, M; Sacks, Frank; Shepherd, James; Tonelli, Marcello; Tonkin, Andrew; School of Public Health: NH&MRC Clinical Trials CentreEffect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease., Circulation 2005, vol.112,(2),2005,pp 171-178